{"id":"bismuth-potassium-citrate","safety":{"commonSideEffects":[{"rate":null,"effect":"Darkening of stool"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Constipation"},{"rate":null,"effect":"Abdominal discomfort"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Bismuth compounds work by creating a barrier that protects the stomach lining from acid and pepsin while simultaneously exhibiting bactericidal effects against H. pylori. The citrate formulation enhances solubility and bioavailability. This dual action makes it effective for treating peptic ulcer disease and H. pylori infection.","oneSentence":"Bismuth potassium citrate forms a protective coating on the gastric mucosa and has antimicrobial activity against Helicobacter pylori.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:28:38.950Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Peptic ulcer disease"},{"name":"Helicobacter pylori infection"},{"name":"Gastritis"}]},"trialDetails":[{"nctId":"NCT06561711","phase":"PHASE4","title":"Optimization of Minocycline for Helicobacter Pylori Rescue Treatment","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2024-08-21","conditions":"Helicobacter Pylori Infection","enrollment":480},{"nctId":"NCT06977841","phase":"NA","title":"Tegoprazan-Based Therapies for H. Pylori Eradication: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Zhongshan Hospital (Xiamen), Fudan University","startDate":"2025-06-10","conditions":"Helicobacter Pylori Eradication, Adverse Reaction","enrollment":640},{"nctId":"NCT07405684","phase":"PHASE4","title":"Fecal Molecular Susceptibility-guided Hp First-line Therapy","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2026-02-28","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":544},{"nctId":"NCT07405697","phase":"PHASE4","title":"Fecal Molecular Susceptibility-guided Hp Rescue Therapy","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2026-02-28","conditions":"Helicobacter Pylori Infection","enrollment":290},{"nctId":"NCT06510010","phase":"PHASE2","title":"Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer","status":"RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2024-12-31","conditions":"Chemotherapy Effect","enrollment":198},{"nctId":"NCT07294846","phase":"PHASE1","title":"Drug Interaction Study on Linaprazan Glurate Capsules","status":"COMPLETED","sponsor":"Jiangsu Sinorda Biomedicine Co., Ltd","startDate":"2025-09-08","conditions":"Healthy Volunteers, Patients","enrollment":56},{"nctId":"NCT05874544","phase":"PHASE4","title":"Rescue Therapy for Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2023-05-16","conditions":"Helicobacter Pylori Infection","enrollment":360},{"nctId":"NCT05857163","phase":"PHASE3","title":"Efficacy and Safety of Rifasutenizol (TNP 2198), Rabeprazole and Amoxicillin in Participants With H. Pylori Infection","status":"COMPLETED","sponsor":"TenNor Therapeutics (Suzhou) Limited","startDate":"2023-05-18","conditions":"H.Pylori Infection","enrollment":700},{"nctId":"NCT06514274","phase":"PHASE4","title":"Study on The Efficacy and Safety of Vonoprazan-containing Berberine Triple Therapy in Helicobacter Pylori First-Line Eradication","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2024-09-20","conditions":"Helicobacter Pylori Infection, Chronic Gastritis","enrollment":558},{"nctId":"NCT06523764","phase":"PHASE4","title":"Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori Initial Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2024-11-11","conditions":"Helicobacter Pylori Infection Chronic Gastrit","enrollment":208},{"nctId":"NCT06760065","phase":"PHASE3","title":"Comparison of Keverprazan Hydrochloride-Amoxicillin Dual Therapy and Susceptibility-Guided Quadruple Therapy for Helicobacter Pylori Rescue Treatment","status":"NOT_YET_RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2025-01-15","conditions":"Helicobacter Pylori Infection Helicobacter Pylori Eradication Patient Education","enrollment":316},{"nctId":"NCT05874570","phase":"PHASE4","title":"Doxycycline for Helicobacter Pylori Rescue Treatment","status":"RECRUITING","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2023-06-20","conditions":"Helicobacter Pylori Infection","enrollment":368},{"nctId":"NCT06332599","phase":"","title":"Minocycline for Helicobacter Pylori Rescue Treatment","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2021-03-01","conditions":"Helicobacter Pylori Infection","enrollment":823},{"nctId":"NCT06561698","phase":"PHASE4","title":"High-dose Dual Therapy and Minocycline-cotaining Quadruple Therapy for Helicobacter Pylori Infection","status":"RECRUITING","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2024-08-21","conditions":"Helicobacter Pylori Infection","enrollment":200},{"nctId":"NCT04531059","phase":"PHASE4","title":"Rescue Therapy for Helicobacter Pylori Eradication Treatment","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2020-10-15","conditions":"Helicobacter Pylori Infection","enrollment":368},{"nctId":"NCT03320538","phase":"NA","title":"Efficacy and Safety of Hou Gu Mi Xi in Patients With Peptic Ulcer Diseases","status":"COMPLETED","sponsor":"Jiangxi University of Traditional Chinese Medicine","startDate":"2017-07-10","conditions":"Peptic Ulcer Disease","enrollment":360},{"nctId":"NCT06351891","phase":"PHASE4","title":"Efficacy and Safety of Bismuth Quadruple Therapy Containing Cefuroxime and Tetracycline as First-line Therapy for Eradicating Helicobacter Pylori in Patients Allergic to Penicillin","status":"UNKNOWN","sponsor":"Qilu Hospital of Shandong University","startDate":"2024-04","conditions":"Helicobacter Pylori Infection","enrollment":248},{"nctId":"NCT05431075","phase":"PHASE4","title":"Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment of Different Tetracycline Doses","status":"COMPLETED","sponsor":"Shandong University","startDate":"2022-07-01","conditions":"Helicobacter Pylori Infection","enrollment":406},{"nctId":"NCT05577468","phase":"PHASE3","title":"Efficacy and Safety of Tegoprazan Versus Esomeprazole-containing Bismuth Quadruple Therapy for Eradication of Helicobacter Pylori","status":"COMPLETED","sponsor":"Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.","startDate":"2022-10-30","conditions":"Helicobacter Pylori Infection","enrollment":561},{"nctId":"NCT06037122","phase":"","title":"Efficacy of Low-dose Vonoprazan for Helicobacter Pylori Eradication","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2023-09","conditions":"Helicobacter Pylori Infection","enrollment":558},{"nctId":"NCT04198363","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"Takeda","startDate":"2020-04-30","conditions":"Helicobacter Pylori","enrollment":510},{"nctId":"NCT04753437","phase":"PHASE1","title":"A Study of Vonoprazan in Adults With Helicobacter Pylori","status":"COMPLETED","sponsor":"Takeda","startDate":"2021-04-06","conditions":"Helicobacter Pylori","enrollment":44},{"nctId":"NCT05049902","phase":"PHASE4","title":"Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication","status":"COMPLETED","sponsor":"Shandong University","startDate":"2021-09-21","conditions":"Helicobacter Pylori Infection","enrollment":1300},{"nctId":"NCT05915871","phase":"PHASE1","title":"Drug Interaction Study Between Tegoprazan, Bismuth, Amoxicillin and Clarithromycin","status":"COMPLETED","sponsor":"Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.","startDate":"2023-03-23","conditions":"Healthy","enrollment":22},{"nctId":"NCT05173493","phase":"","title":"The Study About the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure","status":"COMPLETED","sponsor":"Shandong University","startDate":"2021-12-30","conditions":"Helicobacter Pylori Infection","enrollment":670},{"nctId":"NCT05726734","phase":"PHASE4","title":"Vonoprazan-containing Triple Therapy Versus Empiric Bismuth Quadruple Therapy for First-line Helicobacter Pylori Treatment: a Randomized Clinical Trial","status":"UNKNOWN","sponsor":"Shanghai East Hospital","startDate":"2023-02-06","conditions":"Helicobacter Pylori Infection","enrollment":100},{"nctId":"NCT05438550","phase":"PHASE4","title":"14-day Double Therapy Versus Bismuth Quadruple Therapy in First-line Treatment of Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2023-02-14","conditions":"Helicobacter Pylori Infection","enrollment":258},{"nctId":"NCT05586113","phase":"PHASE4","title":"The Efficacy of 10-day or 14-day Course of Bismuth-containing Quadruple Therapy:A Randomized Clinical Trial","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2023-02-06","conditions":"Helicobacter Pylori Infection","enrollment":398},{"nctId":"NCT05014334","phase":"PHASE4","title":"Study on The Efficacy and Safety of Berberine-containing Triple Therapy in Helicobacter Pylori First-Line Eradication","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2021-12-01","conditions":"Helicobacter Pylori Infection, Chronic Gastritis","enrollment":300},{"nctId":"NCT04879992","phase":"NA","title":"Rifabutin-containing Triple Therapy for Treatment of Helicobacter Pylori","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2021-05-07","conditions":"Helicobacter Pylori Infection","enrollment":413},{"nctId":"NCT04810793","phase":"","title":"The Study on the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure","status":"COMPLETED","sponsor":"Shandong University","startDate":"2020-07-01","conditions":"Helicobacter Pylori","enrollment":820},{"nctId":"NCT05320133","phase":"NA","title":"Jinghua Weikang Capsule Containing Quadruple Therapy for IgAN With Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"Peking University First Hospital","startDate":"2022-06-20","conditions":"Helicobacter Pylori Infection","enrollment":80},{"nctId":"NCT05364619","phase":"NA","title":"Qingre Huashi Granules Combined the Modified Dual Therapy for Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"Peking University First Hospital","startDate":"2022-08-05","conditions":"Helicobacter Pylori Infection","enrollment":160},{"nctId":"NCT05493644","phase":"","title":"A Study About the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2022-09-01","conditions":"Helicobacter Pylori Infection","enrollment":660},{"nctId":"NCT05176821","phase":"NA","title":"Eradication Efficacy and Safety of Two Rescue Treatments for Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2021-01-01","conditions":"H. Pylori Infection","enrollment":186},{"nctId":"NCT05189444","phase":"NA","title":"The Evaluation of Triple Therapy With Vonoprazan, Amoxicillin and Bismuth for Eradication of Helicobacter Pylori","status":"UNKNOWN","sponsor":"Huazhong University of Science and Technology","startDate":"2022-03-25","conditions":"Helicobacter Pylori Infection","enrollment":672},{"nctId":"NCT05250050","phase":"PHASE4","title":"Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2022-03-25","conditions":"Helicobacter Pylori Infection","enrollment":388},{"nctId":"NCT03342456","phase":"PHASE4","title":"The Efficacy and Safety of Ilaprazole/Doxycycline-based Bismuth-containing Quadruple Therapy on Hp Infected Duodenal Ulcers","status":"COMPLETED","sponsor":"The Third Xiangya Hospital of Central South University","startDate":"2017-12-13","conditions":"Duodenal Ulcer Due to Helicobacter Pylori","enrollment":184},{"nctId":"NCT05196945","phase":"PHASE4","title":"Vonoprazan Fumarate in Combination With Amoxicillin for the First-line Eradication of Helicobacter Pylori -- a Multicenter, Randomized, Parallel Controlled Study","status":"UNKNOWN","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2022-03-31","conditions":"Helicobacter Pylori Eradication Rate","enrollment":316},{"nctId":"NCT05135182","phase":"PHASE4","title":"Helicobacter Pylori Rescue Treatment in Patients Allergic to Penicillin","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2021-11-28","conditions":"Helicobacter Pylori Infection","enrollment":170},{"nctId":"NCT05129176","phase":"PHASE4","title":"Helicobacter Pylori First-line Treatment Containing Tetracycline in Patients Allergic to Penicillin","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2021-11-23","conditions":"Helicobacter Pylori Infection","enrollment":106},{"nctId":"NCT03688828","phase":"NA","title":"Evaluation of Saccharomyces Boulardii Combined With Standard Quadruple Therapy for Eradication of Helicobacter Pylori","status":"COMPLETED","sponsor":"Huazhong University of Science and Technology","startDate":"2018-11-11","conditions":"Helicobacter Pylori Infection","enrollment":360},{"nctId":"NCT05061732","phase":"PHASE4","title":"Helicobacter Pylori Eradication and Follow-up","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2021-09-30","conditions":"Helicobacter Pylori Infection","enrollment":4447},{"nctId":"NCT05023577","phase":"PHASE4","title":"Antibiotic Combination for H. Pylori Eradication in Penicillin-allergic Patients","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2021-08-26","conditions":"Helicobacter Pylori Infection","enrollment":504},{"nctId":"NCT05018923","phase":"PHASE4","title":"Tetracycline Versus Doxycycline for HP Rescue Therapy","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2021-08-24","conditions":"Helicobacter Pylori Infection","enrollment":242},{"nctId":"NCT05014685","phase":"PHASE4","title":"PPI-amoxicillin for H. Pylori Treatment","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2021-08-20","conditions":"Helicobacter Pylori Infection","enrollment":732},{"nctId":"NCT03050307","phase":"PHASE3","title":"Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"Takeda","startDate":"2017-04-17","conditions":"Gastric Ulcer","enrollment":234},{"nctId":"NCT04901117","phase":"PHASE4","title":"Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2021-06","conditions":"Helicobacter Pylori Infection","enrollment":1300},{"nctId":"NCT04209933","phase":"PHASE4","title":"Helicobacter Pylori Eradication With Different Bismuth Quadruple Therapies","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2020-05-25","conditions":"Gastric Cancer, Helicobacter Pylori Infection, Bismuth","enrollment":240},{"nctId":"NCT04667299","phase":"PHASE4","title":"Bismuth-Metronidazole Triple Therapy for H. Pylori First-line Treatment","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2020-12-20","conditions":"Helicobacter Pylori Infection","enrollment":270},{"nctId":"NCT03050359","phase":"PHASE3","title":"Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"Takeda","startDate":"2017-04-05","conditions":"Duodenal Ulcer","enrollment":533},{"nctId":"NCT03708848","phase":"PHASE4","title":"Tailored Therapy for Helicobacter Pylori Treatment in Patients With Penicillin Allergy","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2018-12-05","conditions":"Helicobacter Pylori Infection","enrollment":112},{"nctId":"NCT04034641","phase":"PHASE4","title":"Effect of Probiotics on Helicobacter Pylori Eradication","status":"UNKNOWN","sponsor":"Hangzhou Grand Biologic Pharmaceutical, Inc.","startDate":"2019-06-17","conditions":"Helicobacter Pylori Eradication","enrollment":238},{"nctId":"NCT03377933","phase":"NA","title":"The Effects Probiotic Has on Gastromicroecology and Combined With Quadruple Regimen for H Pylori Infection","status":"UNKNOWN","sponsor":"Yiqi Du","startDate":"2019-03-15","conditions":"Efficacy, Gastric Microbiota, Safety","enrollment":40},{"nctId":"NCT03557437","phase":"PHASE4","title":"High Dose of Amoxicillin and Metronidazole Plus Bismuth For Helicobacter Pylori Treatment","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2018-05-25","conditions":"Helicobacter Pylori Infection","enrollment":216},{"nctId":"NCT03730766","phase":"PHASE4","title":"Analysis of the Impact of Helicobacter Pylori on Salivary Microbiome in Adults","status":"UNKNOWN","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2018-08-01","conditions":"Helicobacter Pylori Infection","enrollment":60},{"nctId":"NCT03405584","phase":"PHASE4","title":"High Dose of Dual Therapy Plus Bismuth for Helicobacter Pylori Treatment","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2018-01-03","conditions":"Helicobacter Pylori Infection","enrollment":160},{"nctId":"NCT02935010","phase":"PHASE4","title":"Tailored Versus Empiric Therapy for Helicobacter Pylori Treatment","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2017-02-05","conditions":"Helicobacter Pylori Infection","enrollment":382},{"nctId":"NCT03413020","phase":"PHASE4","title":"Tailored Therapy for Helicobacter Pylori Rescue Treatment","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2018-01-03","conditions":"Helicobacter Pylori Infection","enrollment":200},{"nctId":"NCT02732249","phase":"PHASE4","title":"Clarithromycin Triple Therapy Plus Bismuth for Helicobacter Pylori First-line Treatment","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2016-04-01","conditions":"Helicobacter Pylori Infection","enrollment":66},{"nctId":"NCT02873065","phase":"PHASE4","title":"Efficacy and Safety of 1-week Triple Therapy With Ilaprazole for the Eradication of Helicobacter Pylori","status":"COMPLETED","sponsor":"Livzon Pharmaceutical Group Inc.","startDate":"2014-09","conditions":"Helicobacter Pylori Eradication","enrollment":""},{"nctId":"NCT02835560","phase":"PHASE4","title":"Efficacy and Safety of Ilaprazole Based Bismuth-containing Quadruple Regimen for the First-line Treatment of Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"Livzon Pharmaceutical Group Inc.","startDate":"2013-06","conditions":"Helicobacter Pylori Eradication Antibiotic","enrollment":100},{"nctId":"NCT02175927","phase":"PHASE4","title":"High Dose Amoxicillin Versus Tetracycline as Second-line Treatment of Resistant Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2014-07","conditions":"Helicobacter Pylori Treatment Failure","enrollment":312},{"nctId":"NCT02175901","phase":"PHASE4","title":"Amoxicillin/Metronidazole Based Quadruple Therapy for Helicobacter Pylori Eradication","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2014-07","conditions":"Dyspepsia, Peptic Ulcer","enrollment":215},{"nctId":"NCT01668927","phase":"PHASE4","title":"Empirical Rescue Therapies of Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2012-07","conditions":"Functional Dyspepsia, Scarred Peptic Ulcer","enrollment":424},{"nctId":"NCT01667575","phase":"PHASE4","title":"Efficiency Study of Clarithromycin and Bismuth-containing Quadruple Therapy to Treat H.Pylori","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2012-08","conditions":"Functional Dyspepsia, Peptic Ulcer, Helicobacter Pylori","enrollment":180},{"nctId":"NCT01667718","phase":"PHASE4","title":"Bismuth Improves the Efficacy of Levofloxacin-containing Triple Therapy for Helicobacter Pylori Treatment","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2012-05","conditions":"Functional Dyspepsia, Peptic Ulcer","enrollment":161}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":93,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Bismuth","Bitnal","Bismuth potassium citrate","colloidal bismuth tartrate capsule","Denol"],"phase":"marketed","status":"active","brandName":"Bismuth Potassium Citrate","genericName":"Bismuth Potassium Citrate","companyName":"Shanghai Jiao Tong University School of Medicine","companyId":"shanghai-jiao-tong-university-school-of-medicine","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Bismuth potassium citrate forms a protective coating on the gastric mucosa and has antimicrobial activity against Helicobacter pylori. Used for Peptic ulcer disease, Helicobacter pylori infection, Gastritis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":10,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}